Winther JF, Kenborg L, Byrne J, Hjorth L, Kaatsch P, Kremer LC, et al. Childhood cancer survivor cohorts in Europe. Acta oncologica (Stockholm, Sweden). 2015;54(5):655–68. https://doi.org/10.3109/0284186x.2015.1008648.
Article
Google Scholar
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5–a population-based study. Lancet Oncol. 2014;15(1):35–47. https://doi.org/10.1016/S1470-2045(13)70548-5.
Article
PubMed
Google Scholar
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82. https://doi.org/10.1056/NEJMsa060185.
Article
CAS
PubMed
Google Scholar
Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705–15. https://doi.org/10.1001/jama.297.24.2705.
Article
CAS
PubMed
Google Scholar
Childrens Oncology Group. Long Term Follow-Up guidelines Version 5.0. 2018. (http://www.survivorshipguidelines.orgAccessed 25.08.2020 (October 2018)).
Google Scholar
United Kingdom Children’s Cancer Study Group. Therapy based long term follow-up - Practice Statement. 2005.
Google Scholar
SKION DCOG. Guidelines for follow-up in survivors of childhood cancer 5 years after diagnosis. 2010. (https://www.skion.nl/voor-patienten-en-ouders/late-effecten/533/richtlijn-follow-up-na-kinderkanker/ Accessed 25.08.2020).
Google Scholar
Cooper SL, Brown PA. Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):61–73. https://doi.org/10.1016/j.pcl.2014.09.006.
Article
PubMed
Google Scholar
Mueller S, Chang S. Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2009;6(3):570–86. https://doi.org/10.1016/j.nurt.2009.04.006.
Article
CAS
Google Scholar
Gross TG, Termuhlen AM. Pediatric non-Hodgkin’s lymphoma. Curr Oncol Rep. 2007;9(6):459–65. https://doi.org/10.1007/s11912-007-0064-6.
Article
CAS
PubMed
Google Scholar
Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015;33(27):3029–35. https://doi.org/10.1200/jco.2014.59.4895.
Article
CAS
Google Scholar
Ackland SP, Schilsky RL. High-dose methotrexate: a critical reappraisal. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987;5(12):2017–31. https://doi.org/10.1200/jco.1987.5.12.2017.
Article
CAS
Google Scholar
Hall GW, S. Guidelines for use of HIGH DOSE METHOTREXATE (HDMTX). NHS. 2017. http://tvscn.nhs.uk/wp-content/uploads/2014/09/Cancer-Children-High-Dose-Methotrexate-Guidance-for-Haematolgy-and-Oncology-v2.1-Dec-2015.pdf. Accessed 20.11.2021 2021.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. International journal of surgery (London, England). 2021;88: 105906. https://doi.org/10.1016/j.ijsu.2021.105906.
Article
Google Scholar
Scheinemann K, E; Otth, M; Drozdov, D; Bargetzi M. Late effect of high-dose methotrexate treatment in childhood cancer survivors - a systematic review. 2020. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020212262.
Kremer LC, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2013;60(4):543–9. https://doi.org/10.1002/pbc.24445.
Article
PubMed
Google Scholar
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. https://doi.org/10.1016/j.jclinepi.2010.04.026.
Article
PubMed
Google Scholar
Zając-Spychała O, Pawlak MA, Karmelita-Katulska K, Pilarczyk J, Derwich K, Wachowiak J. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy. Neuroradiology. 2017;59(2):147–56. https://doi.org/10.1007/s00234-016-1777-8.
Article
PubMed
PubMed Central
Google Scholar
Sherief LM, Sanad R, ElHaddad A, Shebl A, Abdelkhalek ER, Elsafy ER, et al. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia. Curr Pediatr Rev. 2018;14(4):253–60. https://doi.org/10.2174/1573396314666181031134919.
Article
CAS
PubMed
PubMed Central
Google Scholar
Halsey C, Buck G, Richards S, Vargha-Khadem F, Hill F, Gibson B. The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. J Hematol Oncol. 2011;4:42. https://doi.org/10.1186/1756-8722-4-42.
Article
PubMed
PubMed Central
Google Scholar
Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(24):3858–64. https://doi.org/10.1200/jco.2006.05.9055.
Article
CAS
Google Scholar
Zając-Spychała O, Pawlak M, Karmelita-Katulska K, Pilarczyk J, Jończyk-Potoczna K, Przepióra A, et al. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate. Leuk Lymphoma. 2018;59(10):2342–51. https://doi.org/10.1080/10428194.2018.1434879.
Article
CAS
PubMed
Google Scholar
Edelmann MN, Daryani VM, Bishop MW, Liu W, Brinkman TM, Stewart CF, et al. Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma. JAMA Oncol. 2016;2(2):201–8. https://doi.org/10.1001/jamaoncol.2015.4398.
Article
PubMed
PubMed Central
Google Scholar
Liu W, Cheung YT, Conklin HM, Jacola LM, Srivastava D, Nolan VG, et al. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Journal of cancer survivorship : research and practice. 2018;12(3):398–406. https://doi.org/10.1007/s11764-018-0679-7.
Article
Google Scholar
Fellah S, Cheung YT, Scoggins MA, Zou P, Sabin ND, Pui CH, et al. Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia. J Natl Cancer Inst. 2019;111(2):201–9. https://doi.org/10.1093/jnci/djy089.
Article
PubMed
Google Scholar
Jansen NC, Kingma A, Schuitema A, Bouma A, Veerman AJ, Kamps WA. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26(18):3025–30. https://doi.org/10.1200/jco.2007.12.4149.
Article
Google Scholar
Jacola LM, Krull KR, Pui CH, Pei D, Cheng C, Reddick WE, et al. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(11):1239–47. https://doi.org/10.1200/jco.2015.64.3205.
Article
CAS
Google Scholar
Grönroos MH, Jahnukainen T, Möttönen M, Perkkiö M, Irjala K, Salmi TT. Long-term follow-up of renal function after high-dose methotrexate treatment in children. Pediatr Blood Cancer. 2008;51(4):535–9. https://doi.org/10.1002/pbc.21650.
Article
PubMed
Google Scholar
Mulder RL, Knijnenburg SL, Geskus RB, van Dalen EC, van der Pal HJ, Koning CC, et al. Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013;22(10):1736–46. https://doi.org/10.1158/1055-9965.Epi-13-0036.
Article
CAS
Google Scholar
Lequin MH, van der Shuis IM, Van Rijn RR, Hop WC, van ven Huevel-Eibrink MM, MuinckKeizer-Schrama SM, et al. Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood. J Clin Densitom. 2002;5(2):167–73. https://doi.org/10.1385/jcd:5:2:167.
Article
CAS
PubMed
Google Scholar
Tillmann V, Darlington AS, Eiser C, Bishop NJ, Davies HA. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2002;17(6):1073–80. https://doi.org/10.1359/jbmr.2002.17.6.1073.
Article
CAS
Google Scholar
van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 2000;35(4):415–20. https://doi.org/10.1002/1096-911x(20001001)35:4%3c415::aid-mpo4%3e3.0.co;2-9.
Article
PubMed
Google Scholar
Cheung YT, Sabin ND, Reddick WE, Bhojwani D, Liu W, Brinkman TM, et al. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. The Lancet Haematology. 2016;3(10):e456–66. https://doi.org/10.1016/s2352-3026(16)30110-7.
Article
PubMed
PubMed Central
Google Scholar
Surtees R, Clelland J, Hann I. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998;16(4):1505–11. https://doi.org/10.1200/jco.1998.16.4.1505.
Article
CAS
Google Scholar
Quinn CT, Griener JC, Bottiglieri T, Hyland K, Farrow A, Kamen BA. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997;15(8):2800–6. https://doi.org/10.1200/jco.1997.15.8.2800.
Article
CAS
Google Scholar
Wen J, Maxwell RR, Wolf AJ, Spira M, Gulinello ME, Cole PD. Methotrexate causes persistent deficits in memory and executive function in a juvenile animal model. Neuropharmacology. 2018;139:76–84. https://doi.org/10.1016/j.neuropharm.2018.07.007.
Article
CAS
PubMed
PubMed Central
Google Scholar
Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and Managing Toxicities of High-Dose Methotrexate. Oncologist. 2016;21(12):1471–82. https://doi.org/10.1634/theoncologist.2015-0164.
Article
CAS
PubMed
PubMed Central
Google Scholar
den Bakker E, Gemke R, Bökenkamp A. Endogenous markers for kidney function in children: a review. Crit Rev Clin Lab Sci. 2018;55(3):163–83. https://doi.org/10.1080/10408363.2018.1427041.
Article
CAS
Google Scholar
Laskin BL, Nehus E, Goebel J, Khoury JC, Davies SM, Jodele S. Cystatin C-estimated glomerular filtration rate in pediatric autologous hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012;18(11):1745–52. https://doi.org/10.1016/j.bbmt.2012.06.006.
Article
CAS
Google Scholar
Nehus EJ, Laskin BL, Kathman TI, Bissler JJ. Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury. Pediatric nephrology (Berlin, Germany). 2013;28(3):453–61. https://doi.org/10.1007/s00467-012-2341-3.
Article
Google Scholar
den Hoed MA, Klap BC, te Winkel ML, Pieters R, van Waas M, Neggers SJ, et al. Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015;26(2):521–9. https://doi.org/10.1007/s00198-014-2878-z.
Article
Google Scholar
Fan C, Georgiou KR, King TJ, Xian CJ. Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children. J Biomed Biotechnol. 2011;2011: 903097. https://doi.org/10.1155/2011/903097.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thomas IH, Donohue JE, Ness KK, Dengel DR, Baker KS, Gurney JG. Bone mineral density in young adult survivors of acute lymphoblastic leukemia. Cancer. 2008;113(11):3248–56. https://doi.org/10.1002/cncr.23912.
Article
PubMed
Google Scholar
Limond JT, S; Bull, KS; Calaminus, G; Lemiere, J; Traunwieser, T; van Santen, HM, Weiler, L; Spoudeas, HA; Chevignard, M. Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years. Eur J Paediatr Neurol. 2020(25):59–67. https://doi.org/10.1016/j.ejpn.2019.10.002.
Jacola LP, M; Lemiere, J; Hudson, MH; Thomas S. Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021(39(16)):1696–704. https://doi.org/10.1200/JCO.20.02444.